Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. January to September 2025 Unaudited Interim Report of the Krka group in Krka.pdf January to September 2025 Unaudited Interim Report of the Krka Group and Krka
  2. Press Release.pdfPress Release

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 48 / 2025
Date of issue: 2025-11-13
Short name of the issuer
KRKA
Subject
Unaudited interim report of the Krka Group and Krka for the period January to September 2025
Official market - legal basis
Art. 56. 1. 2 of Act on Public Offering
Unofficial market - legal basis
Contents of the report:
Based on Article 26 of the Rules of the Ljubljana Stock Exchange, the company Krka, d. d., Novo mesto publishes the Unaudited interim Report of the Krka Group and Krka, d. d., Novo mesto for the nine months ended 30 September 2025.


The report will be published on the Company's website (www.krka.biz) from 13 November 2025 onwards, for a minimum period of 5 years.
Annexes
File Description
January to September 2025 Unaudited Interim Report of the Krka group in Krka.pdf
January to September 2025 Unaudited Interim Report of the Krka group in Krka.pdf
January to September 2025 Unaudited Interim Report of the Krka Group and Krka
Press Release.pdf
Press Release.pdf
Press Release

KRKA, TOVARNA ZDRAVIL D.D.
(fullname of the issuer)
KRKA Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
8501 Nove Mesto
(post code) (city)
Smarjeska 6
(street) (number)
+386 7 331 21 11 +386 7 332 15 37
(phone number) (fax)
(e-mail) (web site)
nie dotyczy
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2025-11-13 Jože Colarič President of the Management Board and CEO
20251113_081552_1310808501_January_to_September_2025_Unaudited_Interim_Report_of_the_Krka_group_in_Krka.pdf

20251113_081552_1310808501_Press_Release.pdf